The use of extracorporeal membrane oxygenation (ECMO) for both severe respiratory and cardiac failure is increasing. Because these patients are some of the sickest in the intensive care unit, a multidisciplinary approach to their treatment, including appropriate nutrition therapy, is warranted. Currently, limited data exist on the optimal timing, type, and amount of nutrition to be provided. This review focuses on describing the current nutrition practices in patients receiving ECMO, details research that is currently being undertaken, and lists important research questions that require exploration in this field. Observational data suggest that early enteral nutrition is safe and that although nutrition targets can be met, underfeeding is still common. Until further research is available, these patients should be fed according to guidelines for the general critically unwell population. (Nutr Clin Pract. 2018;33:738-746) 
Introduction
Extracorporeal membrane oxygenation (ECMO) is a lifesaving supportive therapy used for patients with severe respiratory and/or cardiac failure. ECMO for adult cardiorespiratory failure has seen significant growth in the last decade, following the influenza A (H1N1) pandemic of 2009-2011 1 and the conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR) study. 2 ECMO has 2 configurations: venovenous (VV), which is used for respiratory support, and venoarterial (VA), which is used for cardiac support. To provide ECMO, blood is drained from the great veins and passed through a gas exchange membrane that adds oxygen and removes carbon dioxide; the blood is then returned to the circulation into either the right atrium (VV ECMO) or aorta (VA ECMO). 3, 4 Despite the fact that these patients are some of the sickest and most resource-intensive patients in the intensive care unit (ICU), there is a paucity of data regarding the optimum timing, type, and amount of nutrition support that should be provided. Indeed, the Extracorporeal Life Support Organization, the umbrella organization of ECMO providers, includes only 1 line regarding nutrition support in their Guidelines for Adult Respiratory Failure, which states "full energy and protein support is essential." 5 This lack of guidance is reflected in the significant variation in feeding practices reported both in the United Kingdom and internationally. 6, 7 However, it is acknowledged that investigating nutrition support practices to improve outcome and recovery in these patients is warranted. 8 There is much debate surrounding optimum nutrition support practices for the general critically ill patient; however, the importance of avoiding overfeeding in the early stages of critical illness is agreed on. 9 Given patients receiving ECMO are some of the most acutely unwell in the ICU, this point may be even more relevant, and differences in responses to feeding strategies between patients receiving VV and VA ECMO may be present.
We aim to provide a comprehensive review of the evidence surrounding the provision and management of nutrition support in adult patients receiving ECMO, and provide some questions to direct future research in this area.
Timing and Route of Nutrition Support
Concerns about the safety of early enteral nutrition (EN) in critically ill patients exist, particularly in those patients who are in significant states of shock (inadequate organ perfusion) and receiving high-dose vasopressors (commonly adrenergic drugs). 9 For these reasons, historical practices encouraged withholding, or at least delaying, EN during ECMO support. 10 However, recent European guidelines 11 have recommended that early EN is safe and feasible in these patients, albeit based on expert opinion. Seven observational studies were found describing nutrition practices in patients receiving ECMO (both VV and VA). 10, [12] [13] [14] [15] [16] [17] In these studies (Table 1) , EN was most frequently commenced within 24 hours of starting ECMO, with several studies reporting a mean or median time to feeding of around 13 hours. In the largest study, 16 96% of patients were fed within 24 hours. The reporting of adverse events is rare and likely to be impacted on by the predominantly retrospective nature of the studies, but in a prospective multicenter observational study of 107 patients, 5 patients (4.5%) were reported to have bowel ischemia. 15 This was a population of 60% VA ECMO and 40% VV ECMO patients, but it is not known which type of ECMO those patients who experienced bowel ischemia were receiving. Thus, it cannot be determined whether this occurrence was due solely to the underlying disease, due in part to support with ECMO, or contributed to by the EN strategy. However, a recent retrospective observational study of patients receiving VA ECMO for at least 2 days and receiving early EN reported that early EN was associated with both lower in-hospital (hazard ratio [HR] 0.78, 95% CI: 0.62-0.98, P = .032) and 28-day mortality (HR 0.74, 95% CI: 0.56-0.97, P = .031). 18 Despite this finding, prospective randomized controlled trials are warranted because only 12% of patients received early EN, and reasons for feeding decisions cannot be elucidated. Indeed, in a recent large trial of EN vs early parenteral nutrition (PN) in critically ill patients with shock who were receiving vasopressor support, there was no difference in the primary outcome of 28-day all-cause mortality. 19 However, those in the EN group had higher rates of adverse gastrointestinal events. 19 Notably, more patients in the EN group suffered bowel ischemia (19 Nasogastric feeding is the most common route of nutrition support reported in all studies. Use of postpyloric feeding appears to be infrequent overall, although rates of up to 33% have been reported. 16 Postpyloric feeding tube placement is more difficult and takes a longer time to achieve than gastric placement; however, successful insertion rates of >90% using a bedside placement technique with an electromagnetic device have been reported. 20 The relative acceptability and perceived utility of gastric compared with postpyloric feeding appears to vary between institutions and countries, with an international survey of feeding practices in adult patients receiving ECMO reporting that postpyloric feeding is most commonly used in the United States compared with other countries. 7 It may also indicate that this method of feeding may be more common in centers who are experienced at bedside placement techniques in their general ICU cohort.
The reported use of PN, either alone or in combination with EN, ranges from 4% to 30% of patients receiving ECMO support. The use of PN in patients receiving ECMO remains controversial because of the possibility of lipid infiltration into the oxygenator causing oxygenator failure. 21 However, data supporting this are limited and although it is clearly a possibility, it is not currently possible to make evidence-based recommendations as to the appropriate use of PN during ECMO. 22 In addition, newer generation membranes used in the circuit may now negate this risk. 8 Given this, if PN is deemed to be in the best interest of the patients on nutrition grounds, it is worth ensuring that close monitoring of the ECMO circuit is undertaken when patients are receiving PN, especially if other lipid-containing 
Dose of Nutrition Support
The optimal dose of nutrition support in terms of energy and protein in the critically ill population is unknown, 9 and this is also true for patients receiving ECMO. The American Society for Parenteral and Enteral Nutrition guidelines 23 recommend the use of a nutrition risk scoring tool in all critically ill patients to determine the level of attention paid to the dose of both energy and protein. However, given that severity of illness scoring systems are reliant on physiology and age, it is likely that they underestimate the severity of illness on ECMO because physiology is manipulated, patients are commonly younger than the average ICU patient, patients may have been in the ICU for some days before commencing ECMO, and patients tend to have a longer ICU stay. Consequently, it is likely that current nutrition risk scores may systematically underestimate the actual risk, and individualized nutrition support regimens should be provided to these patients.
Energy
Indirect calorimetry (IC) is considered the gold standard for determining energy expenditure (EE) in critically ill adults and is recommended as first-line choice in evidence-based nutrition guidelines. 23, 24 IC determines EE by measuring the amount of oxygen inhaled and carbon dioxide exhaled, and relies on several assumptions including a stable distribution of carbon dioxide and knowledge of nitrogen loss. 25 Measuring IC in patients receiving ECMO needs to take into account gas exchange via the native lung and via the membrane lung, and also the impact of recirculation. Recirculation adds an error into the calculation because both the carbon dioxide and oxygen exchange across the membrane lung can be underestimated. Recirculation also varies based on the state of intravascular blood volume, as well as thoraco-abdominal compliance and cardiac output. Recirculation fraction can be measured using ultrasonic techniques.
Two studies 26, 27 have demonstrated it is possible to measure EE in patients receiving ECMO in 2 ways. De Waele et al 27 described a method whereby EE is first measured in the native lung via the ventilator; then the metabolic cart is connected to the ECMO circuit to measure at the artificial lung. Both numbers are then added together and inserted into the Weir equation for calculation. Along with the timeconsuming nature of this method, the authors report that they used an in-house, custom-made adaptor to connect the metabolic cart to the ECMO circuit, which is not available elsewhere. Wollersheim et al 26 presented an alternative method that still requires measurement of gas exchange using IC at the native lung, but rather than connecting the IC to the ECMO circuit, blood gas is measured before and after the membrane oxygenator, with carbon dioxide and oxygen content being subsequently calculated using a referenced equation. 28 The Weir equation is then used to determine EE. Both protocols provide an opportunity for EE to be measured in patients receiving ECMO, but require prospective validation, particularly at different time points during the ECMO run because EE is not static and different blood flow rates may influence the measurement. However, these methods will most certainly allow further investigations into the optimum energy targets for patients receiving both VA and VV ECMO.
As with general ICU patients, when IC is not available, predictive or weight-based equations are the method of choice for determining energy targets in patients receiving ECMO, 10 29 who found that MEE in patients receiving ECMO was on average 19 kcal/kg, albeit in a group of only 6 patients. The differences in these 2 studies may be because of different methods used to measure EE or differences in ECMO; one included only VV ECMO patients, 26 whereas the other included both VV and VA ECMO patients. 29 This underscores the importance of undertaking further research in this area and using clinical judgment at the bedside when estimating energy targets in these patients.
In the absence of nutrition guidelines specifically for patients receiving ECMO, it appears reasonable to follow currently available guidelines for general critically unwell patients that recommend IC where available or weight-based equations ranging from 20 to 25 kcal/kg. 23, 24 European Society for Parenteral and Enteral Nutrition guidelines 24 go on to further recommend 25-30 kcal/kg when the patient has moved into the recovery phase of critical illness. With more and more patients being liberated from the ventilator and mobilizing out of bed while still receiving ECMO, 30, 31 it may be suitable to increase energy provision to 30 kcal/kg when a patient is in this phase of recovery despite still receiving ECMO. However, currently, no studies have measured EE in ambulatory patients receiving ECMO.
Improved outcomes have been demonstrated in general ICU patients receiving around 80% of their estimated energy targets 32 and 70% of measured energy targets, 33 which is likely to be comparable in patients receiving ECMO. Although often the most unwell patients in an ICU, studies have shown it is possible for patients receiving ECMO to achieve and tolerate this target. Ferrie et al 13 reported that 60% of their patients receiving ECMO received >80% of the estimated energy targets, and more recently MacGowan et al 16 showed that 89.8% of target energy was delivered to patients receiving VV ECMO. However, in the latter study, underfeeding was still common with patients receiving <80% of their energy targets on one-quarter of feeding days. Interestingly, both studies found a difference in the energy delivered in the ECMO and post-ECMO periods, with those in the post-ECMO period receiving more. It is thought that the reason for this relates to both gastric/enteral feeding intolerance and to the greater number of procedures requiring cessation of EN during the ECMO run. 16 When considering the relationship of the dose of energy to clinical outcome in adult patients with ECMO, little data exist. However, receiving adequate energy intake (>80%) was associated with longer length of stay in 1 study. 16 It is not known whether this is simply due to the patients who remained in the ICU longer being able to reach nutrition targets, or whether there is a true burden associated with nutrition that increases length of stay. In contrast, in a retrospective study of Taiwanese patients receiving ECMO, achieving >80% of nutrition targets was associated with improved mortality. 17 It is clear that prospective randomized controlled trials are required to further investigate these findings.
Protein
Recommendations for protein intakes in the critically ill range from 1.2 g/kg/d for the general ICU patient up to 2.5 g/kg/d for those who are obese or admitted with burns or after trauma. 23, 24 However, these recommendations are based on limited, mainly observational data. The assumed benefit of providing adequate protein is a reduction in skeletal muscle wasting, which may lead to improved physical function post-ICU. 34 Providing adequate protein to patients receiving ECMO may be particularly important because of the significant amount of muscle wasting experienced. Recently, the trajectory of muscle wasting, measured using muscle ultrasound, in patients receiving both VV and VA ECMO was reported. In line with critically ill, non-ECMO patients, rectus femoris cross-sectional area had decreased by 19% at day 10 and 30% at day 20. 35 Other quadriceps muscles also decreased in size to a similar degree. Smaller muscle size (total muscle thickness) was associated with lower strength and mobility score. 36 Only 1 study aiming to investigate optimum protein intakes in patients receiving ECMO exists. This small study investigated the nitrogen balance in obese and nonobese adult patients receiving VV ECMO. 37 Protein targets were set at 1.5-2.0 g/kg/d for nonobese patients and 2.0-2.5 g/kg/d for obese patients, with around 85% of this target being delivered. Results were compared between obese and nonobese individuals, and it was concluded that obese compared with nonobese patients had a more negative nitrogen balance (−1.7 ± 5.7 vs −11.5 ± 9.6). Despite the fact that nitrogen balance has inherent limitations that make interpretation in the critically ill population difficult, 38 these data provide some initial insights into the nitrogen balance and potential protein requirements in these patients, and this topic should certainly be explored further.
From existing observational data undertaken in patients receiving ECMO, a minimum 1.2 g/kg/d is targeted for protein in clinical practice. Although there is a discrepancy between prescribed and delivered protein intakes, it is possible to meet >80% of the prescribed target, 16, 17 which has been shown to lead to lower mortality in critically ill, non-ECMO patients. 33, 39 Whether meeting current recommendations for protein intake in this patient population improves outcomes not related to muscle wasting is unknown, but higher protein intakes were associated with a longer length of stay in the largest observational study. 16 However, as mentioned previously, these data were not adjusted for length of stay. Until further data are available, it would not seem unreasonable to aim for protein intakes in line with the general critically ill population accounting for clinical condition and factors such as the use of continuous renal replacement therapy.
Barriers to the Delivery of EN
Delayed gastric emptying is frequently cited as a complication associated with enteral feeding in patients receiving ECMO. 6, 12, 15, 16 This was confirmed in a United Kingdom-wide survey of nutrition practices in patients receiving VV ECMO, where 69% of responders reported that ࣙ50% of their patients require prokinetics while receiving VV ECMO. 6 However, the definition of delayed gastric emptying is based on gastric residual volumes (GRVs), and there are a variety of thresholds ranging from 150 to 300 mL. Furthermore, in the observational studies reported to date, those with a lower acceptable GRV report a higher incidence of medications used to promote gastric emptying than those with a higher GRV threshold. Where a GRV of 150 mL is accepted and postpyloric feeding not used, prokinetic use is 71%-95%. 10, 12 Furthermore, there are other approaches, including use of postpyloric feeding, on an ad hoc or planned basis, which alter the utility of GRV measurements. It is not currently known what an ideal GRV threshold is, or indeed whether they should be measured at all. 40 The largest observational study to date indicated that prokinetics/postpyloric feeding was used in >50% of their patients with the result being that >80% of the energy and protein targets were delivered. 16 This indicates that with a flexible approach to nutrition support, underfeeding can be avoided. Although patients in this study were all receiving VV ECMO, Ferrie et al 13 reported no difference in the incidence of enteral feeding intolerance between those receiving VA and VV ECMO, so the common belief that VA ECMO reduces gut perfusion and therefore reduces motility may not hold true in modern-day clinical practice.
Delayed gastric emptying is not the only barrier to delivering EN in these patients. Both MacGowan et al 16 and Ridley et al 15 reported bedside and operating room procedures to be the most frequent reason for enteral feeding interruptions, occurring in >30% of patients. This is also a frequently cited reason for feeding interruptions in the general critically ill population, and strategies such as volume-based feeding have proven useful in preventing the associated poor delivery of nutrition. 41 However, volume-based feeding has not been studied specifically in patients receiving ECMO, but should not be discounted as an option, particularly in the more stable patient. Certainly guidelines directing when EN should be stopped and started for procedures have been shown to increase nutrition targets in non-ECMO centers 42 and should be considered as standard practice for all critically ill patients.
Studies Planned or in Progress
A search of clinical trials databases was undertaken to determine details of any studies that are in progress investigating aspects of nutrition in patients receiving ECMO. Only 3 studies were found. 
Potential Research Questions
No prospective randomized controlled trials exist examining the optimum route, timing, or adequacy of nutrition support in patients receiving ECMO, but it is clear that these are urgently required. Because VA and VV patients may be different in terms of their metabolic sequelae, we recommend that VA and VV patients are recruited and investigated separately, or at least subgroup analysis is considered for each group where they have been recruited together. The Intensive Care Medicine research agenda for extracorporeal life support acknowledges the limited evidence surrounding the optimal feeding strategy for these patients. 8 Although nutrition did not feature in the top 10 recommended research trials for these patients, early rehabilitation/mobilization did. We would propose that nutrition and rehabilitation go hand in hand, 34, 43 and encourage investigators to report appropriate nutrition parameters in any of these future studies.
We have outlined 5 research questions that we feel are priorities to answer:
1. What is the optimum energy intake in patients receiving VV and VA ECMO? 2. What is the optimum protein intake in patients receiving VV and VA ECMO? 3. What is the impact of nutrition support on the physical and functional recovery of patients receiving VA and VV ECMO? 4. What are the optimum energy and protein targets during rehabilitation in patients receiving ECMO?
5. Are nutrient losses (micronutrients and macronutrients) present across the ECMO membrane, and are these losses clinically meaningful?
Conclusion
The use of ECMO as a lifesaving treatment for both severe respiratory and cardiac failure is increasing. It is clear that these patients are some of the sickest in the ICU and require a multidisciplinary approach to treatment that includes appropriate nutrition therapy. Currently, there are limited data to guide nutrition therapy, but it appears that early EN is safe. Until further data are available, nutrition should be provided in line with current guidelines for critically ill patients. Prospective randomized controlled trials investigating optimal nutrition in these patients are urgently required. 
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